DeepCyto
DeepCyto, founded in 2018 and headquartered in Tianjin, China, is a technology company that integrates artificial intelligence and deep learning into hematological pathology diagnosis and data analysis. The company offers customized AI-assisted diagnostic products and technical services for medical institutions, focusing on improving the accuracy and efficiency of hematological diagnoses. Their innovative solutions include the DCS-1600 cell morphology analyzer and the Deepflo® flow cytometry AI cloud diagnostic platform, positioning them as a leader in the AI healthcare sector in China.
DeepCyto
DeepCyto, founded in 2018 and headquartered in Tianjin, China, is a technology company that integrates artificial intelligence and deep learning into hematological pathology diagnosis and data analysis. The company offers customized AI-assisted diagnostic products and technical services for medical institutions, focusing on improving the accuracy and efficiency of hematological diagnoses. Their innovative solutions include the DCS-1600 cell morphology analyzer and the Deepflo® flow cytometry AI cloud diagnostic platform, positioning them as a leader in the AI healthcare sector in China.